Autonomix Medical (AMIX) Competitors $2.08 +0.11 (+5.80%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$2.07 -0.01 (-0.48%) As of 04/25/2025 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX vs. QTI, IRIX, XAIR, LFWD, VVOS, NRXS, PETV, CODX, BTCY, and PAVMShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include QT Imaging (QTI), IRIDEX (IRIX), Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), NeurAxis (NRXS), PetVivo (PETV), Co-Diagnostics (CODX), Biotricity (BTCY), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. QT Imaging IRIDEX Beyond Air ReWalk Robotics Vivos Therapeutics NeurAxis PetVivo Co-Diagnostics Biotricity PAVmed Autonomix Medical (NASDAQ:AMIX) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking. Which has more risk & volatility, AMIX or QTI? Autonomix Medical has a beta of -3.08, indicating that its stock price is 408% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Do analysts recommend AMIX or QTI? Autonomix Medical presently has a consensus price target of $28.00, suggesting a potential upside of 1,246.15%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than QT Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00QT Imaging 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation and earnings, AMIX or QTI? QT Imaging has higher revenue and earnings than Autonomix Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$15.43M-$12.93-0.16QT Imaging$4.00M4.96-$4.03MN/AN/A Does the media favor AMIX or QTI? In the previous week, Autonomix Medical had 2 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Autonomix Medical and 1 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.88 beat Autonomix Medical's score of 0.93 indicating that QT Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QT Imaging 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals believe in AMIX or QTI? 10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in AMIX or QTI? Autonomix Medical received 1 more outperform votes than QT Imaging when rated by MarketBeat users. CompanyUnderperformOutperformAutonomix MedicalOutperform Votes1100.00% Underperform VotesNo VotesQT ImagingN/AN/A Is AMIX or QTI more profitable? QT Imaging's return on equity of 0.00% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -212.48% -161.13% QT Imaging N/A N/A -65.94% SummaryQT Imaging beats Autonomix Medical on 8 of the 13 factors compared between the two stocks. Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.12M$4.33B$5.46B$7.81BDividend YieldN/A46.43%5.43%4.26%P/E Ratio-0.1630.7422.4318.45Price / SalesN/A53.00391.42101.46Price / CashN/A51.0838.1834.62Price / Book0.266.146.684.19Net Income-$15.43M$68.15M$3.22B$248.05M7 Day Performance12.31%4.65%6.25%6.54%1 Month Performance9.76%-6.33%-2.70%-1.97%1 Year Performance-96.90%28.36%16.86%4.72% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical3.2852 of 5 stars$2.08+5.8%$28.00+1,246.2%-96.9%$5.12MN/A-0.161News CoverageQTIQT ImagingN/A$0.67-5.0%N/A-11.0%$18.04M$4.00M0.00N/APositive NewsGap DownIRIXIRIDEX2.1401 of 5 stars$1.02-1.0%$2.00+96.1%-57.5%$17.13M$48.67M-1.52120Analyst ForecastNews CoverageXAIRBeyond Air4.4194 of 5 stars$0.22-3.1%$3.67+1,536.9%-81.3%$15.48M$3.02M-0.2170News CoverageHigh Trading VolumeLFWDReWalk Robotics2.5414 of 5 stars$1.43-0.3%$9.00+531.6%-68.4%$14.94M$25.66M-0.5660News CoverageVVOSVivos Therapeutics2.7694 of 5 stars$2.26+2.5%$6.10+170.5%+1.5%$13.28M$15.03M-0.40160Short Interest ↓Positive NewsGap DownNRXSNeurAxisN/A$1.90+18.4%N/A-24.9%$13.06M$2.69M-0.9819News CoverageHigh Trading VolumePETVPetVivoN/A$0.50-3.8%N/A-29.3%$12.11M$1.05M-1.1120News CoverageCODXCo-Diagnostics4.2143 of 5 stars$0.35-1.2%$1.00+184.9%-68.5%$11.78M$3.92M-0.25100Positive NewsGap DownBTCYBiotricityN/A$0.46+7.0%N/A-64.1%$11.46M$12.06M-0.4340Gap UpPAVMPAVmed4.4916 of 5 stars$0.67+1.5%$19.50+2,832.3%-55.8%$11.37M$3.00M-0.1590Short Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies QT Imaging Competitors IRIDEX Competitors Beyond Air Competitors ReWalk Robotics Competitors Vivos Therapeutics Competitors NeurAxis Competitors PetVivo Competitors Co-Diagnostics Competitors Biotricity Competitors PAVmed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMIX) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.